EZH2 Promotes Cisplatin Resistance by Reducing Cellular Platinum Accumulation

Cancer Science - United States
doi 10.1111/cas.13599
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

TNFAIP8 Promotes Cisplatin Resistance in Cervical Carcinoma Cells by Inhibiting Cellular Apoptosis

Oncology Letters
Cancer ResearchOncology
2019English

MicroRNA-221 Promotes Cisplatin Resistance in Osteosarcoma Cells by Targeting PPP2R2A

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

RING Domain–deficient BRCA1 Promotes PARP Inhibitor and Platinum Resistance

Journal of Clinical Investigation
Medicine
2016English

Heparan Sulfate Proteoglycan-Mediated Entry Pathway for Charged Tri-Platinum Compounds: Differential Cellular Accumulation Mechanisms for Platinum

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2012English

Cross-Resistance of Platinum Derivatives in H-1r, a Cisplatin-Resistant Cell Line

Oncology Reports
MedicineCancer ResearchOncology
1994English

CLEC4M Is Associated With Poor Prognosis and Promotes Cisplatin Resistance in NSCLC Patients

Journal of Cancer
Oncology
2019English

Regrowth Resistance: Low-Level Platinum Resistance Mediated by Rapid Recovery From Platinum-Induced Cell-Cycle Arrest

2009English

Layer‐by‐Layer Nanoparticles for Novel Delivery of Cisplatin and PARP Inhibitors for Platinum‐Based Drug Resistance Therapy in Ovarian Cancer

Bioengineering & Translational Medicine
2019English

FEN1 Promotes Tumor Progression and Confers Cisplatin Resistance in Non-Small-Cell Lung Cancer

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy